Chemed Reports Second-Quarter 2018 Results - Earnings Guidance Increased
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Chemed (CHE) PT Raised to $340 at Oppenheimer
July 27, 2018 9:37 AM EDTOppenheimer raised its price target on Chemed (NYSE: CHE) to $340.00 (from $315.00) while maintaining a Outperform rating.
Analyst Michael Wiederhorn commented, "CHE reported 2Q:18 adj. EPS of $2.81 (GAAP: $3.27) vs. OPCO/Street ests. of $2.68/$2.77. Adj. results exclude the normal items (OIG/stock... More



